TRPM7 and ovarian carcinoma: Given that glycolysis inhibition is associated with HIF-1α degradation we hypothesize that TRPM7 activation may modulate the HIF-1α/AMPK signaling to regulate glucose metabolism and promote ovarian cancer cell proliferation.